share price, page-17

I bought more today - once US approval comes there should be a good jump in SP.It's just a waiting game at the moment. Lack of news always raises the anxiety level.

The risk of a delay or non-approval still has to be factored in (however small) and I think this would be significantly holding the SP back.

I also think people underappreciate what a huge problem ulcers are. I'm a physio and see the huge costs of ulcers every day at work in the hospital. For non-medical people I can imagine that fixing ulcers isn't that easy to get excited about compared to a cardiovascular drug or cancer drug.